References
- Paramo J A, Colucci M, Collen D. Plasminogen activator inhibitor in the blood of patients with coronary artery disease. B M J 1985; 291: 573–4
- Hamsten A, Wiman B, deFaire U, Blomback M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557–63
- Juhan-Vague I, Valadier J, Alessi M C, et al. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost 1987; 57: 67–72
- Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 1990; 227: 273–8
- Vague Ph, Juhan-Vague I, Aillaud M F, Badoer Ch, Viard M Ch A, Collen D. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects. Metabolism 1986; 35: 250–63
- Landin K, Stigendal L, Eriksson E, et al. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 1990; 39: 1044–8
- Alessi M C, Juhan-Vague I, Kooistra T, Declerck P J, Collen D. Insulin stimulates the synthesis of plasminogen activator inhibitor 1 by the human hepatocellular cell line Hep G2. Thromb Haemost 1988; 60: 491–4
- Kooistra T, Bosma P J, Tons H AM, van den Berg A P, Meyer P, Princen H MG. Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thromb Haemost 1989; 62: 723–8
- Grant P J, Kruithof E KO, Felley C P, Feber J P, Bachmann F. Short-term infusions of insulin, triacyl-glycerol and glucose do not cause acute increases in plasminogen activator inhibitor-1 concentrations in man. Clin Sci 1990; 79: 513–6
- Landin K, Tengborn L, Chmielewska J, von Schenck H, Smith U. The acute effect of insulin on tissue plasminogen activator and plasminogen activator inhibitor in man. Thromb Haemost 1991; 65: 130–3
- Vuorinen-Markkola H, Puhakainen I, Yki-Jarvinen H. No evidence for short-term regulation of plasminogen activator inhibitor activity by insulin in man. Thromb Haemost 1992; 67: 117–20
- Helm A. Insulin and blood fibrinolytic activity. Thrombos Diathes Haemorrh 1973; 29: 293–9
- Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis 1990; 10: 1067–73
- Mussoni L, Mannucci L, Sirtori M, et al. Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler Thromb 1992; 12: 19–27
- Følling I, Norman N. Hyperglycemia, hypoglycemic attacks, and production of anti-insulin antibodies without previous known immunization. Diabetes 1972; 21: 814–26
- Rånby M, Sundell B, Nilsson T. Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity. Thromb Haemost 1989; 62: 917–22
- Chmielewska J, Rånby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427–36
- Wiman B, Mellbring G, Rånby M. Plasminogen activator release during venous stasis and exercise as determined by a new specific assay. Clin Chim Acta 1983; 127: 279–88
- Grimaudo V, Hauert J, Bachmann F, Kruithof E KO. Diurnal variation of the fibrinolytic system. Thromb Haemost 1988; 59: 495–9
- Gader A MA, Clarkson A R, Cash J D. The plasminogen activator and coagulation factor VIII responses to adrenaline, noradrenaline, isoprena-line and salbutamol in man. Thromb Res 1973; 2: 9–16
- Berne C, Fagius J, Niklasson F. Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings. J Clin Invest 1989; 84: 1403–9
- Kleinbaum J, Shamoon H. Selective counter regulatory hormone response after oral glucose in men. J Clin Endocrinol Metab 1982; 55: 787–90